Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pain, Injection site pruritus, Injection site rash, Pain in extremity
Clinical narrative: injection site with RASH; injection site redness Redness; Itchiness on the injection site; A little burn on injection site; Arm soreness; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE RASH (injection site with RASH), PAIN IN EXTREMITY (Arm soreness), INJECTION SITE ERYTHEMA (injection site redness Redness), INJECTION SITE PRURITUS (Itchiness on the injection site) and INJECTION SITE PAIN (A little burn on injection site) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Cholesterol since an unknown date, Restless leg syndrome since an unknown date and Anxiety since an unknown date. Concomitant products included ESCITALOPRAM OXALATE (LEXAPRO) for Anxiety, FENOFIBRATE (TRICOR [FENOFIBRATE]) for Cholesterol, CLONAZEPAM for Restless leg syndrome, CYANOCOBALAMIN (VITAMIN B12 [CYANOCOBALAMIN]), VITAMIN D NOS, VITAMIN D3 (VITAMIN D3 2000IU) and VACCINIUM MACROCARPON (CRANBERRY NS) for an unknown indication.    On 07-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Jan-2021, the patient experienced PAIN IN EXTREMITY (Arm soreness). On 14-Jan-2021, the patient experienced INJECTION SITE RASH (injection site with RASH), INJECTION SITE ERYTHEMA (injection site redness Redness), INJECTION SITE PRURITUS (Itchiness on the injection site) and INJECTION SITE PAIN (A little burn on injection site). On 09-Jan-2021, PAIN IN EXTREMITY (Arm soreness) outcome was unknown. At the time of the report, INJECTION SITE RASH (injection site with RASH), INJECTION SITE ERYTHEMA (injection site redness Redness), INJECTION SITE PRURITUS (Itchiness on the injection site) and INJECTION SITE PAIN (A little burn on injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient applied OTC Cortisone on the site to relieve the itchiness. This case was received via an unknown source (no reference has been entered for a regulatory authority or license partner) on 23-Jan-2021 and was forwarded to Moderna on 24-Jan-2021.    This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE RASH (injection site with RASH), PAIN IN EXTREMITY (Arm soreness), INJECTION SITE ERYTHEMA (injection site redness Redness), INJECTION SITE PRURITUS (Itchiness on the injection site) and INJECTION SITE PAIN (A little burn on injection site) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Cholesterol since an unknown date, Restless leg syndrome since an unknown date and Anxiety since an unknown date. Concomitant products included ESCITALOPRAM OXALATE (LEXAPRO) for Anxiety, FENOFIBRATE (TRICOR [FENOFIBRATE]) for Cholesterol, CLONAZEPAM for Restless leg syndrome, CYANOCOBALAMIN (VITAMIN B12 [CYANOCOBALAMIN]), VITAMIN D NOS, VITAMIN D3 (VITAMIN D3 2000IU) and VACCINIUM MACROCARPON (CRANBERRY NS) for an unknown indication.    On 07-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Jan-2021, the patient experienced PAIN IN EXTREMITY (Arm soreness). On 14-Jan-2021, the patient experienced INJECTION SITE RASH (injection site with RASH), INJECTION SITE ERYTHEMA (injection site redness Redness), INJECTION SITE PRURITUS (Itchiness on the injection site) and INJECTION SITE PAIN (A little burn on injection site). On 09-Jan-2021, PAIN IN EXTREMITY (Arm soreness) outcome was unknown. At the time of the report, INJECTION SITE RASH (injection site with RASH), INJECTION SITE ERYTHEMA (injection site redness Redness), INJECTION SITE PRURITUS (Itchiness on the injection site) and INJECTION SITE PAIN (A little burn on injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient applied OTC Cortisone on the site to relieve the itchiness.